ror rate of Fisher’s least signiﬁcant differ-ence test. J Am Statistical Assoc 396:1000– 1004, 1986 21. Davis JE, McDonald JM, Jarret L: A high-performance liquid chromatogra-phy method for hemoglobin A1c. Dia- betes 27:102–107, 1978 22. Cole RA, Soeldner JS, Dunn PJ, Bunn HF: A rapid method for the determination ofglycosylated hemoglobins using highpressure liquid chromatography. Metabo- lism27:289–301, 1978 23. Weyer C, Bogardus C, Mott DM, Pratley RE: The natural history of insulin secre-tory dysfunction and insulin resistance inthe pathogenesis of type 2 diabetes melli-tus.J Clin Invest 104:787–794, 1999 24. Harris MI, Eastman RC, Cowie CC, Flegal KM, Eberhardt MS: Racial and ethnic dif-ferences in glycemic control of adults withtype 2 diabetes. Diabetes Care 22:403– 408, 1999 25. Inzucchi SE: Oral antihyperglycemic therapy for type 2 diabetes: scientiﬁc re-view. JAMA 287:360–372, 2002 26. Egan JM, Clocquet AR, Elahi D: The insu-